Antihypertensive medication use in older patients transitioning from chronic kidney disease to End-Stage renal disease on dialysis

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 8, 2016, Pages 1401-1412

  Chang, Tara I ^a   Zheng, Yuanchao ^a   Montez Rath, Maria E ^a   Winkelmayer, Wolfgang C ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

ACE inhibitors; acute kidney injury; antihypertensive agents; blood pressure; cardiovascular disease; coronary artery disease; hospitalization; humans; hyperkalemia; kidney failure, chronic; renal dialysis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COMORBIDITY; CORONARY ARTERY DISEASE; DIALYSIS; END STAGE RENAL DISEASE; FEMALE; HEALTH CARE; HEMODIALYSIS; HUMAN; HYPERKALEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SCANNING ELECTRON MICROSCOPY; SYSTOLIC HEART FAILURE; VERY ELDERLY; ACUTE KIDNEY FAILURE; COMBINATION DRUG THERAPY; DISEASE EXACERBATION; HEART FAILURE; HYPERTENSION; PATHOPHYSIOLOGY; PRESCRIPTION; STATISTICS AND NUMERICAL DATA;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; CORONARY DISEASE; DISEASE PROGRESSION; DIURETICS; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HUMANS; HYPERKALEMIA; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 85006411848     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10611015     Document Type: Article

References (30)

1. Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM: Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol 6: 2642-2649, 2011
2. Foley RN, Chen SC, Solid CA, Gilbertson DT, Collins AJ: Early mortality in patients starting dialysis appears to go unregistered. Kidney Int 86: 392-398, 2014
3. Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, O’Hare AM, Pisoni R, Plattner B, Port FK, Rao P, Rhee CM, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, Eggers PW, Agodoa LY, Abbott KC: US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. AmJ KidneyDis 66[Suppl 1]: S1-S305, 2015
4. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E: 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311: 507-520, 2014
5. Wheeler DC, Becker GJ: Summary of KDIGOguideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int 83: 377-383, 2013
6. National Kidney Foundation: KDOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45(Suppl 3):S1-S154, 2005
7. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103: 987-992, 2001
8. Takahashi A, Takase H, Toriyama T, Sugiura T, Kurita Y, Ueda R, Dohi Y: Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study. Nephrol Dial Transplant 21: 2507-2512, 2006
9. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479, 2009
10. Cice G, Di Benedetto A, D’Isa S, D’Andrea A, Marcelli D, Gatti E, Calabrò R: Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebocontrolled trial. J AmColl Cardiol 56: 1701-1708, 2010
11. Chang TI, Desai M, Solomon DH, Winkelmayer WC: Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J AmSocNephrol 6: 864-869, 2011
12. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF, Kontos MC, Wiviott SD; Acute Coronary Treatment and Intervention Outcomes Network registry: Use of evidencebased therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: A report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation 121: 357-365, 2010
13. Frankenfield DL, Weinhandl ED, Powers CA, Howell BL, Herzog CA, St Peter WL: Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D. Am J Kidney Dis 59: 670-681, 2012
14. Sood MM, Battistella M, Lok CE: Patterns of cardioprotective medication prescription in incident hemodialysis patients. Int Urol Nephrol 41: 1021-1027, 2009
15. Lopes AA, Bragg-Gresham JL, Ramirez SP, Andreucci VE, Akiba T, Saito A, Jacobson SH, Robinson BM, Port FK, Mason NA, Young EW: Prescription of antihypertensive agents to haemodialysis patients: Time trends and associations with patient characteristics, country and survival in theDOPPS. Nephrol Dial Transplant 24: 2809-2816, 2009
16. Rahman M, Griffin V: Patterns of antihypertensivemedication use in hemodialysis patients. Am J Health Syst Pharm 61: 1473-1478, 2004
17. U.S. Renal Data System: USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013
18. Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH: Identification of individuals with CKD from Medicare claims data: A validation study. Am J Kidney Dis 46: 225-232, 2005
19. Chang TI, Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA, Winkelmayer WC: Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J AmSoc Nephrol 23: 2042-2049, 2012
20. Li Q, Glynn RJ, Dreyer NA, Liu J, Mogun H, Setoguchi S: Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients. Pharmacoepidemiol Drug Saf 20: 700-708, 2011
21. Fischer MA, Vogeli C, Stedman M, Ferris T, Brookhart MA, Weissman JS: Effect of electronic prescribing with formulary decision support on medication use and cost. Arch Intern Med 168: 2433-2439, 2008
22. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D: Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27: 299-309, 2002
23. Zou G: A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159: 702-706, 2004
24. U.S. Renal Data System: 2015 USRDS annaul data report: Epidemiology of kidney disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2015
25. St Peter WL, Sozio SM, Shafi T, Ephraim PL, Luly J, McDermott A, Bandeen-Roche K, Meyer KB, Crews DC, Scialla JJ, Miskulin DC, Tangri N, Jaar BG, Michels WM, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators: Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. BMC Nephrol 14: 249, 2013
26. Levey AS, Rocco MV, Anderson S, Andreoli SP, Bailie GR, Bakris GL, Callahan MB, Greene JH, Johnson CA, Lash JP, McCullough PA, Miller ER, Nally JV, Pirsch JD, Portman RJ, Sevick MA, Sica D, Wesson DE, Agodoa L, Bolton K, Cutler JA, Hostetter T, Lau J, Uhlig K, Chew P, Kausz A, Kupelnick B, Raman G, Sarnak M, Wang C, Astor BC, Eknoyan G, Levin A, Levin N, Bailie G, Becker B, Becker G, Burrowes J, Carrera F, Churchill D, Collins A, Crooks PW, DeZeeuw D, Golper T, Gotch F, Gotto A, Greenwood R, Greer JW, Grimm R, Haley WE, Hogg R, Hull AR, Hunsicker L, Klag M, Klahr S, Lameire N, Locatelli F, McCulloch S, Michael M, Newmann JM, Nissenson A, Norris K, Obrador G, Owen W, Patel TG, Payne G, Ronco C, Rivera-Mizzoni RA, Schoolwerth AC, Star R, Steffes M, Steinman T, Wauters JP, Wenger N, Briggs J, Burrows-Hudson S, Latos D, Mapes D, Oberley E, Pereira BJG, Willis K, Gucciardo A, Fingerhut D, Klette M, Schachne E: K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43: (SUPPL 1), 2004
27. Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, Cruz JM, Akiba T, Kurokawa K, Ramirez S, Young EW: Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis 49: 426-431, 2007
28. Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC: Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: Comparisons of benefit type and benefit phase. JManag Care Spec Pharm 20: 862-876, 2014
29. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
30. Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E: Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: ImprovingGlobalOutcomes (KDIGO). Kidney Int 80: 572-586, 2011